Glucagon-like peptide-1 therapy and the exocrine pancreas: innocent bystander or friendly fire?

Diabetologia. 2010 Jan;53(1):1-6. doi: 10.1007/s00125-009-1591-5. Epub 2009 Nov 6.
No abstract available

Publication types

  • Comment

MeSH terms

  • Animals
  • Disease Models, Animal
  • Glucagon-Like Peptide 1 / therapeutic use*
  • Humans
  • Hyperplasia / drug therapy
  • Pancreas, Exocrine / drug effects*
  • Pancreatic Ducts / drug effects
  • Pancreatic Ducts / pathology
  • Pancreatitis / drug therapy*
  • Pancreatitis, Chronic / drug therapy
  • Pancreatitis, Chronic / physiopathology
  • Rats
  • United States
  • United States Food and Drug Administration

Substances

  • Glucagon-Like Peptide 1